World Biomaterials Congress

Presentation on Multifunctionality of Ozonized Glycerin (Novel Glycerin Compounds) and Their Application as Biomaterials at the World Biomaterials Congress

Mediplus Pharma, Inc. (CEO: Kenji Ito, HQ: Shibuya, Tokyo) presented on the multifunctionality and application of its proprietary ingredient, ozonized glycerin (Novel Glycerin Compound), as biomaterials at the 12th World Biomaterials Congress (WBC), held over six days from May 26 to 31, 2024, in Daegu, South Korea.

For more details on the press release, please visit here.